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has had a profound impact on many areas of immuno-Alexander J. Bankovich and K. Christopher Garcia*
logical research (Garboczi et al., 1992). Hence, the sys-Department of Microbiology and Immunology
tems chosen for such studies need to be selected veryDepartment of Structural Biology
carefully to ensure that the final result will reveal someStanford University School of Medicine
novel aspects and provide new information key to under-Fairchild D319
standing the immunological experiments.299 Campus Drive
Future structural challenges in T cell recognition canStanford, California 94305
be broken down into large-scale macromolecular dock-
ing questions (Figure 1B) versus those that define the
fine atomic details of the TCR/pMHC interaction. These
latter details are far less dramatic to the uninformed eyeAlthough our structural understanding of T cell recog-
than macromolecular topology questions but are reallynition has rapidly evolved due to recent crystallo-
where the answers lie to many of the most elusive andgraphic results, the reality is that detailed answers to
fundamental immunological questions. The large-scalemany of the most fundamental questions still remain
docking issues are clearly focused on how the variouselusive. In this issue, high-resolution insight into the
coreceptors all fit together into a functional TCR signal-phenomenon of TCR chain bias takes down another
ing complex (Figure 1B). While a recent NMR structurebrick from the wall.
of a covalently-linked CD3 heterodimer has been re-
ported (Sun et al., 2001), we still do not know how it
engages the TCR. Perhaps that odd “protrusion,” theIn perhaps no other branch of biomedical sciences has
FG loop in the C domain of the TCR, has a role inthe potential of structural biology been realized more
docking to CD3 (Figure 1B)? Studies from the Reinherzvividly than in immunology. From the initial illuminating
and Karjaleinen labs, which have deleted this loop incrystal structures of antibody-antigen complexes to the
different TCRs, appear to be at odds with each other,breathtaking first glimpse of an MHC molecule to recent
in one case showing a fully functional TCR (Degermannbreakthroughs with T cell and other antigen receptor
et al., 1999), while in another resulting in aberrant signal-complexes, we have come to expect high drama from
ing capabilities (Sasada et al., 2002). Alternatively, athe often marathon-like crystallographic endeavors.
structure in this issue of Immunity suggests that confor-In particular regard to T cell recognition, it is still early,
mational change in the TCR C AB loop could be wherebut we can glean some “moderate resolution” principles
the action is (Kjer-Nielsen et al., 2003). Hence, the dispo-that have emerged from the relatively few unique TCR/
sition of the CD3 components (, , , ), which are anpMHC complex structures which comprise the current
integral fixture of the TCR-CD3 complex, has yet to bedatabase (Figure 1A) (two class II complexes, six class
determined. We now have complexes of class I and III complexes) (reviewed in Hennecke and Wiley, 2001;
MHC with CD8 and CD4 (Gao et al., 1997; Wang et al.,Rudolph and Wilson, 2002). We use the term moderate
2001), respectively, and these have been fantasticallyresolution not in the crystallographic sense of ang-
revealing in that there appears to be little chance forstroms but rather in the level of insight these structures
simultaneous coreceptor binding to both MHC and TCRhave given us into fundamental immunological princi-
(Figure 1B) (discussed below). However, in the absenceples. We can say with some assurance that: (1) all TCRs
of the entire TCR/CD3/CD4 or CD8 complexes, conclu-will recognize pMHC with a roughly diagonal orientation,
sions about higher order assemblies derived from crys-
(2) the CDR3s have a primary role in readout of the
tal structures of binary complexes could be deceiving,
bound peptide antigen, while CDRs 1 and 2 tend to
and remain speculative. The persistent controversy
recognize conserved features of the MHC helices, (3) about TCR oligomerization (Baker and Wiley, 2001;
conformational change in the TCR CDR loops appears Davis et al., 1998) during signaling has not been clarified
to be a primary mechanism to enhance TCR crossreac- by structural studies of the incomplete complexes (Fig-
tivity, and (4) structural complementarity in the TCR/ ure 1B), which have so far not revealed any dimeric TCR/
pMHC interface plays an important role in the half-life pMHC complexes but instead have revealed a mixed
and functional consequences of TCR/pMHC interactions bag of monomers.
(Figure 1A). Turning to the details, perhaps the holy grail of TCR/
Given that the technical challenges inherent in crystal- pMHC structural studies is to describe the structural
lization of these complexes remain daunting, an impor- basis of MHC restriction. It may come as a surprise to
tant issue is whether further structures of TCR/pMHC many readers of Immunity, but we still have no idea how
complexes, which incrementally recapitulate these prin- or why, at a structural level, the TCR repertoire is biased
ciples, are redundant and of limited value to the field toward recognition of MHC. How is it that all  TCRs
as a whole. Disappointingly, no general strategy has have some degree of reactivity with all MHC molecules
emerged for production and crystallization of the  (Germain, 1990), as necessitated for thymic education
TCR, as has been the case for class I MHC, for which (Nikolic-Zugic and Bevan, 1990) and TCR scanning of
the Wiley group reported a refolding methodology that MHC in the periphery (Wu et al., 2002)? Despite roughly
similar diagonal docking orientations over MHC (35
from diagonal for all complexes to date), the TCR/pMHC*Correspondence: kcgarcia@stanford.edu
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Figure 1. Past, Present, and Future Structural Issues in T Cell Recognition
(A) Recurrent structural features of TCR/pMHC complexes to date.
(B) Model of TCR-CD3-CD4 components within a T cell/APC interface (adapted from Wang et al., 2001).
complex crystal structures do not share sets of common specificity. It will require a large number of structures,
in concert with focused immunogenetic experiments, tocontacts (Hennecke and Wiley, 2001; Rudolph and Wil-
son, 2002). One argument is that our V gene repertoires glean the rules—if they exist.
A related question, whose answer lies within the struc-have evolved to only retain segments that will assume
diagonal docking on the MHC. However, one can also tural details of TCR/MHC complexes, is the basis for
the phenomenon of chain bias. For MHC recognition, inargue that there may be many alternative orientations
possible by random  pairs, but the thymus serves as principle, anyTCR pair should serve as an acceptable
framework to endow with specificity for any pMHCa filtering step through which only the diagonal orienta-
tions can pass. The early notion that the thymic filter through CDR3 diversification. However, experimental
evidence has shown that certain antigens induce awas the monomorphic CD4 and CD8 coreceptors bridg-
ing TCR and MHC through conserved binding epitopes highly restricted TCR repertoire from the almost limitless
number of possible  pairs, while other antigens selecton both, and thus enforcing a convergent topology on
all TCR/MHC complexes, no longer appears plausible. a roughly random set of TCR heterodimers. One of the
most striking examples is in the CTL response that arisesRecent structures of both CD8 and CD4 complex with
MHC I and II, respectively, show that it is unlikely that naturally to Epstein Barr Virus. In this issue of Immunity,
Kjer-Nielsen et al. describe the first structure of a TCR/these coreceptors will make contact with the TCR (Fig-
ure 1B) (Gao et al., 1997; Wang et al., 2001). Hence, the pMHC complex composed of a “public” TCR (LC13) that
is almost exclusively selected by HLA-B8 individualsTCR is free to assume any rotational docking topology
on the MHC, yet somehow a common solution is en- for reactivity toward the latent antigen EBNA 3A (Kjer-
Nielsen et al., 2003). As virtually all CTL against thisforced. The answer to this enigma likely lies within the
interatomic contacts of the TCR/MHC interface, but the antigen use the LC13 TCR, it is the most extreme exam-
ple of chain bias known and, therefore, serves as adatabase of structures is not yet large enough for
the conserved or cryptic epitope(s) to reveal itself in an perfect target for structural studies to explain this phe-
nomenon. Prior to this result, one could fathom a numberobvious fashion. Perhaps, similar to the notion of anchor
motifs defining rules for peptide binding to MHC, there of possible explanations to account for TCR chain bias
(Figure 2) (Wallace et al., 2000). Some explanations havewill exist sets of anchor points between certain  pairs
and MHC haplotypes (Madden, 1995) that define an nothing to do with the structural aspects of the antigen
recognition. For instance, perhaps regulatory T cells areoverall geometry, while the remaining contacts impart
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B8/FLRGRAYGL. In the complex, the principal finding
is that an interconnected network of interactions from
both V and J germline segments, as well as recombined
N-, P-, and D-encoded segments, form specific contacts
with both peptide and MHC. Many of these contacts
are only possible for the TRAV26-2 V and TRBV7-8 V
used by LC13. The indirect nature of some of the highly
specific contacts is exemplified, for instance, by a water-
mediated hydrogen bond between the most critical pep-
tide residue P7-Tyr and V framework residue His48 and
CDR1 residue Tyr31. But the origin of the exquisite
specificity is far more complicated than is revealed by
simply adding up TCR/pMHC contacts. Upon binding
the pMHC, a number of the CDR loops have undergone
extensive conformational changes, disrupting their ca-
nonical unbound structures, to new conformations dic-
tated by the recognition of HLA-B8/FLRGRAYGL. Aston-
ishingly, one residue in CDR3, Pro93, appears to play
a key role as a “crumple point” to enable this CDR to
adopt to a conformation optimal for peptide readout.
The necessity of Pro93, then, is not for direct antigen
recognition but rather as an enabler of an ancillary struc-
tural rearrangement. And yet, such enabling residues
throughout the LC13 binding site are no less critical to
the final recognition solution as the residues participat-Figure 2. Possible Selective Pressures that Could Lead to Chain
Bias in a TCR Repertoire ing directly in interatomic contacts. While more dramatic
examples of TCR conformational change have been pre-
viously documented (Reiser et al., 2002), the concept ofinduced by EBV that suppress a broad TCR repertoire
conserved noncontact enabling residues is very enlight-against antigens necessary for the persistence of this
ening and suggests new levels of complexity in under-virus in its latent form. Or possibly LC13 may be en-
standing TCR/pMHC interactions. In total, both germlinedowed with nearly perfect affinity/avidity characteris-
and nongermline encoded sequences conspire to or-tics, giving it a significant signaling advantage during
chestrate a cooperative relay of inter- and intramolecu-positive selection, while other  pairs may be deleted
lar interactions by, and within, the LC13 binding site todue to crossreactivity with self-antigens (Figure 2). These
achieve the final recognition mode. Underscoring thescenarios necessarily imply that, in principle, many pos-
selective pressure on the LC13 TCR is the observation
sible TCR  pairs in the germline repertoire can effec-
that many of the individual clones settle on the same
tively recognize and lyse cells that present the HLA-
CDR3 and  amino acid sequences using different re-
B8 peptide complex (HLA-B8/FLRGRAYGL). However,
combination strategies, revealed at the nucleotide se-
there may be a “hole in the repertoire,” such that the quence level (Kjer-Nielsen et al., 2002). Hence, the re-
LC13 TCR comprises the only pair of  sequences in striction to LC13 is not based on some advantage
our entire V gene set, which, working in concert as a conferred during recombination by the LC13 germline
heterodimer, is capable of recognizing this antigen (Fig- DNA segments. Given multiple possible CDR3 sequence
ure 2). This latter scenario is unlikely, given that hetero- solutions for recognition of HLA-B8/FLRGRAYGL, there
zygotic HLA-B8/B44 individuals, who cannot select the is an exclusive convergence on LC13. This unequivo-
LC13 TCR due to self-tolerance, generate a robust and cally tells us that the answer to why LC13 lies at the
diverse repertoire of TCRs with specificity for HLA-B8/ heart of the TCR/pMHC interaction chemistry.
FLRGRAYGL. Finally, work from the Carbone group in What, then, is the advantage of this recognition solu-
the Herpes Simplex Virus (HSV) system has shown that tion over other possible modes of recognition by other
TCR immunodominance can arise from preferential J TCR  pairs? The structure clearly tells us why LC13
region usage, which is neighboring and can be part of is a very good choice, but it does not tell us why it is
the binding interface with pMHC (Figure 2) (Wallace et the only TCR which CTL will use in these individuals.
al., 2000). Since J and J form part of the VV domain Certainly, LC13 has not achieved some notably higher
interface in the  heterodimer, it may be that the set affinity for pMHC than other TCRs, as the rough estimate
of interactions between the particular J regions of LC13 of Kd is only 50 	M. One clue may be inferred from an
are exclusive to one another and force the chain bias, interesting structural feature in this complex, a confor-
rather than a unique antigen structure. This fact, though, mational change in the Cdomain AB loop (Kjer-Nielsen,
would not explain the convergence on identical CDR3 2003). As these authors had the opportunity to compare
amino acid sequences, which are not entirely encoded in bound versus free TCR structures (Kjer-Nielsen et al.,
the J region, that interact with the bound EBNA peptide 2002), they observed a significant difference in a loop
antigen. on the surface of the C domain that would appear
The crystal structure clearly tells us that the invariant poised for contact with CD3 subunits. From the initial
nature of LC13 is due to the fine-tuned and refined struc- TCR structures, the unusual noncanonical Ig-fold struc-
ture of the TCR Cdomain has been a puzzling deviationtural chemistry required for efficient recognition of HLA-
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from the more standard domain structures of the rest of the models that structural biologists have proposed
of the TCR (Garcia et al., 1996). The loose packing of using the “lego building block” strategy to piece to-
the top strands has been proposed to be an ideal loca- gether larger assemblies from smaller pieces. For in-
tion for an induced fit-type interaction with CD3. One of stance, in the mature synapse of the 2B4 TCR com-
the most critical issues in T cell recognition remains plexed with I-Ek, CD4 appears to be excluded from the
how TCR engagement leads to activation. Somehow, central core to a ring surrounding the TCR/MHC clusters
the CD3 subunits, which are docked alongside the TCR (Grakoui et al., 1999). Obviously, this puts the idea of a
constant domains, must sense ligand binding. The TCR/ stable trimolecular TCR/MHC/CD4 signaling complex
pMHC recognition event is not simply a means to bring into question. A recent experiment from the Davis lab
two molecules together, but the TCR is a conduit for proposes the rather novel idea that the bridging ability of
sensing subtle structural differences and translating CD4 may, in fact, rely on the CD4 ectodomain grasping
these differences into graded biological responses. The MHC-II at the N-terminal end, while the C-terminal region
structural rearrangement seen in the LC13 C loop is of the same CD4 molecule grasps another TCR/pMHC
by far the most thought-provoking evidence, so far, that complex to form a “pseudo-dimer” (Irvine et al., 2002).
a type of conformational transduction may accompany In any case, the common knowledge that soluble CD4,
ligand binding, as has been recently shown for CD3 CD8, and CD3 ectodomain constructs do not have mea-
itself (Gil et al., 2002). The weakness of this supposition, surable solution affinities for soluble TCR suggests we
though, is that we have not seen such a change in nu- are all in for a surprise when we finally see how they all
merous other TCR/pMHC complexes and also that the fit together. It may be that lipid and membrane compo-
conformational change could simply reflect an inherent nents indigenous to rafts are necessary to reconstitute
flexibility in that region of the structure. Further, the key these multipartite signaling complexes.
missing link is a structural explanation of how ligation No structure of a TCR/pMHC complex is completely
at the TCR binding site is communicated to this small redundant at this early stage of the game; each signifi-
loop that is a great distance away from the TCR/pMHC cantly adds to our knowledge base. Over 100 crystal
interface. As always, this structure can now inform and structures of antibody-antigen complexes have been
focus further functional experiments aimed at ad- deposited in the PDB database, yet we continue to learn
dressing these important questions. new principles about antibody-antigen and, more gener-
Our goal in this minireview is to give a sense that, ally, protein-protein recognition with new structures
although our structural understanding of T cell recogni- from carefully chosen and revealing systems. Will the
tion is being furthered by studies of the kind described delineation of principles for T cell recognition require
by Kjer-Nielsen et al. in this issue, it is far from complete. the same plethora of structural information as antibody-
The picture of a TCR/pMHC complex may say a thou- antigen complexes? Most certainly not, given that we
sand words, but the dictionary for the language of T cell are much more computationally advanced at modeling
recognition will contain millions of words. Many, if not and analyzing protein structures than at any point in the
most, of the core questions in T cell immunology remain past. However, the message for the future is clearly to
future challenges for structural biology. Unlike antibody- identify systems whose structural study will lift us from
antigen and most receptor-ligand interactions, TCRs ap- our current plateau to the next levels of understanding,
pear to possess the ability to respond differentially to either in the large-scale complex docking issues or in the
MHC-bound peptides of very different chemical and fine details of peptide-MHC recognition and restriction.
structural composition. So far, we have seen structures
of single TCRs with highly related peptide variants, but Acknowledgments
we have yet to see how a TCR can recognize vastly
We would like to thank I.A. Wilson, E.J. Adams, and M.M. Davis fordifferent structural entities, as has been clearly demon-
helpful discussions.strated in functional studies. The concept of molecular
mimicry in autoimmunity, whereby a microbial pathogen
Selected Readinginduces autoreactivity to a self-antigen remains only a
hypothesis (Oldstone, 1987). We do not have structures
Baker, B.M., and Wiley, D.C. (2001). Immunity 14, 681–692.
of an autoimmune TCR complexed with both autoanti-
Davis, M.M., Boniface, J.J., Reich, Z., Lyons, D., Hampl, J., Arden,gen and crossreactive, perhaps microbial, peptide-MHC B., and Chien, Y. (1998). Annu. Rev. Immunol. 16, 523–544.
complexes. Is there really “structural mimicry” or in fact
Degermann, S., Sollami, G., and Karjalainen, K. (1999). J. Exp. Med.
are the different pMHC ligands being recognized in en- 189, 1679–1684.
tirely unique fashions? The extension of the crossreac-
Gao, G.F., Tormo, J., Gerth, U.C., Wyer, J.R., McMichael, A.J., Stuart,
tivity question is how both structurally similar and dis- D.I., Bell, J.I., Jones, E.Y., and Jakobsen, B.K. (1997). Nature 387,
similar ligands can activate the TCR to varying extents. 630–634.
The simple relation between TCR/MHC complex half- Garboczi, D.N., Hung, D.T., and Wiley, D.C. (1992). Proc. Natl. Acad.
life and bioactivity now has numerous exceptions, so Sci. USA 89, 3429–3433.
what are the physical principles by which the recognition Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson,
at the TCR combining site is translated into a signaling M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). Science
274, 209–219.outcome?
As a last point, structural studies in T cell recognition Germain, R.N. (1990). Nature 344, 19–22.
increasingly need to dovetail with the emerging concept Gil, D., Schamel, W.W., Montoya, M., Sanchez-Madrid, F., and Alar-
of the immunological synapse (Grakoui et al., 1999). con, B. (2002). Cell 109, 901–912.
Some of the results from fluorescent imaging experi- Grakoui, A., Bromley, S.K., Sumen, C., Davis, M.M., Shaw, A.S.,
Allen, P.M., and Dustin, M.L. (1999). Science 285, 221–227.ments of TCR/APC interactions run counter to many
Minireview
11
Hennecke, J., and Wiley, D.C. (2001). Cell 104, 1–4.
Irvine, D.J., Purbhoo, M.A., Krogsgaard, M., and Davis, M.M. (2002).
Nature 419, 845–849.
Kjer-Nielsen, L., Clements, C.S., Purcell, A.W., Brooks, A.G., Whiss-
tock, J.C., Burrows, S.R., McCluskey, J., and Rossjohn, J. (2003).
Immunity 18, this issue, 53–64.
Kjer-Nielsen, L., Clements, C.S., Brooks, A.G., Purcell, A.W.,
McCluskey, J., and Rossjohn, J. (2002). Structure 10, 1521–1532.
Madden, D.R. (1995). Annu. Rev. Immunol. 13, 587–622.
Nikolic-Zugic, J., and Bevan, M.J. (1990). Nature 344, 65–67.
Oldstone, M.B. (1987). Cell 50, 819–820.
Reiser, J.B., Gregoire, C., Darnault, C., Mosser, T., Guimezanes, A.,
Schmitt-Verhulst, A.M., Fontecilla-Camps, J.C., Mazza, G., Malis-
sen, B., and Housset, D. (2002). Immunity 16, 345–354.
Rudolph, M.G., and Wilson, I.A. (2002). Curr. Opin. Immunol. 14,
52–65.
Sasada, T., Touma, M., Chang, H.C., Clayton, L.K., Wang, J.H., and
Reinherz, E.L. (2002). J. Exp. Med. 195, 1419–1431.
Sun, Z.J., Kim, K.S., Wagner, G., and Reinherz, E.L. (2001). Cell 105,
913–923.
Wallace, M.E., Bryden, M., Cose, S.C., Coles, R.M., Schumacher,
T.N., Brooks, A., and Carbone, F.R. (2000). Immunity 12, 547–556.
Wang, J.H., Meijers, R., Xiong, Y., Liu, J.H., Sakihama, T., Zhang,
R., Joachimiak, A., and Reinherz, E.L. (2001). Proc. Natl. Acad. Sci.
USA 98, 10799–10804.
Wu, L.C., Tuot, D.S., Lyons, D.S., Garcia, K.C., and Davis, M.M.
(2002). Nature 418, 552–556.
